» Articles » PMID: 39832209

Effect of Targeted Education of Patients with Atrial Fibrillation on Unplanned Cardiovascular Outcomes: Results of the Multicentre Randomized AF-EduCare Trial

Overview
Journal Europace
Date 2025 Jan 20
PMID 39832209
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Trials on integrated care for atrial fibrillation (AF) showed mixed results in different AF populations using various approaches. The multicentre, randomized AF-EduCare trial evaluated the effect of targeted patient education on unplanned cardiovascular outcomes.

Methods And Results: Patients willing to participate were randomly assigned to in-person education, online education, or standard care (SC) and followed for minimum 18 months. Education focused on four aspects of integrated AF care: (i) knowledge on AF and oral anticoagulation; (ii) reinforcement of medication adherence; (iii) awareness about risk factors; and (iv) reachability for AF-related questions. The primary endpoint was the composite of cumulative events of unplanned cardiovascular hospitalizations and consultations, emergency department visits for cardiovascular reasons, and cardiovascular death. A total of 1038 patients (69.8 ± 9.2 years) were followed up for 26.9 ± 9.4 months. Education (both in-person and online) significantly improved AF-related knowledge compared to SC (P < 0.001), increased patient awareness about risk factors, led to high medication adherence, and encouraged patients to ask health-related questions. However, in-person education did not show an effect on the primary outcome compared to SC [HR 1.02 (0.91-1.14); P = 0.80] that was also not the case when comparing online education vs. SC [HR 1.18 (0.95-1.46), P = 0.65]. Exploratory subgroup analyses showed a heterogeneous effect over the centres, but a positive impact of in-person education in patients with asymptomatic AF, being 70 years old or younger, and without a history of heart failure.

Conclusion: AF-EduCare showed that intensive targeted patient education did not lead to less unplanned cardiovascular events in the AF patient population as a whole, although subgroups might benefit.

References
1.
Delesie M, Knaepen L, Dendale P, Vijgen J, Ector J, Verbeeck J . Effect of targeted education for atrial fibrillation patients: Design of the EduCare-AF Study. Eur J Clin Invest. 2020; 51(1):e13442. DOI: 10.1111/eci.13442. View

2.
Lane D, Ponsford J, Shelley A, Sirpal A, Lip G . Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy: effects of an educational intervention programme. The West Birmingham Atrial Fibrillation Project. Int J Cardiol. 2005; 110(3):354-8. DOI: 10.1016/j.ijcard.2005.07.031. View

3.
van den Dries C, van Doorn S, Rutten F, Oudega R, van de Leur S, Elvan A . Integrated management of atrial fibrillation in primary care: results of the ALL-IN cluster randomized trial. Eur Heart J. 2020; 41(30):2836-2844. PMC: 7421774. DOI: 10.1093/eurheartj/ehaa055. View

4.
Vinereanu D, Lopes R, Bahit M, Xavier D, Jiang J, Al-Khalidi H . A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial. Lancet. 2017; 390(10104):1737-1746. DOI: 10.1016/S0140-6736(17)32165-7. View

5.
Guo Y, Guo J, Shi X, Yao Y, Sun Y, Xia Y . Mobile health technology-supported atrial fibrillation screening and integrated care: A report from the mAFA-II trial Long-term Extension Cohort. Eur J Intern Med. 2020; 82:105-111. PMC: 7553102. DOI: 10.1016/j.ejim.2020.09.024. View